The novel STAR assay can rapidly determine telomere dysregulation in cancers and age-related diseases in clinical settings.
Since autumn 2019, the Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF-funded ERA-NET project “NExT” that aims […]
A new type of breast cancer drug can help halt progression of disease and is not toxic, according […]
Researchers are preparing to launch clinical trials of a drug used to cure a deadly disease caused by […]
A new study looked at how pharmacogenomics could improve the safety and effectiveness of COVID-19 drug therapies.
An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight […]
The interactive tool highlights unprecedented cross-sector collaboration
Idefirix is an immunosuppressant that reduces the level of donor specific antibodies, thus enabling transplantation
It is hoped that the vaccine will generate protection not only against SARS-CoV-2, but also against new strains […]
Blenrep is a first-line inhibitor of BCMA, a cell-surface protein that plays a crucial role in the survival […]